Clinical Trial Update: Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This study evaluated tamoxifen citrate decision aids for women at increased risk of breast cancer in Phase 1 and Phase 2, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen citrate (tamoxifen citrate)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED